Priming of immune responses to hepatitis B surface antigen in young mice immunized in the presence of maternally derived antibodies

被引:25
作者
Weeratna, RD
Millan, CLB
McCluskie, MJ
Siegrist, CA
Davis, HL
机构
[1] Coley Pharmaceut Canada, Ottawa, ON K1Y 4E9, Canada
[2] Ottawa Hosp, Loeb Hlth Res Inst, Ottawa, ON, Canada
[3] Univ Geneva, Dept Pathol & Pediat, WHO, Collaborating Ctr Neonatal Vaccinol, Geneva, Switzerland
[4] Univ Ottawa, Fac Hlth Sci, Sch Rehabil Sci, Ottawa, ON, Canada
[5] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada
来源
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY | 2001年 / 30卷 / 03期
基金
英国医学研究理事会;
关键词
immunization; CpG ODN; DNA vaccine; maternally transferred antibody;
D O I
10.1016/S0928-8244(01)00231-0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Early vaccination is necessary to protect infants from various infectious diseases. However. this is often unsuccessful largely due to the immaturity of the neonatal immune system. Furthermore, maternally derived antibodies can interfere with active immunization. We have previously shown in young mice that immune responses against several different antigens can be improved by the addition of oligodeoxynucleotides containing immunostimulatory CpG motifs (CpG ODN). In this study we have evaluated immunization of neu born (1-7-day-old) BALB/c mice against hepatitis B surface antigen (HBsAg), with alum and/or CpG ODN, in the presence of high levels of maternal antibody against HBsAg (anti-HBs). Seroconversion rates and anti-HBs titers were compared to those induced by a HBsAg-expressing plasmid, since other studies had suggested DNA vaccines to be superior to protein vaccines in young mice with maternal antibody. HBsAg/alum/CpG ODN was superior to DNA vaccine in inducing HBsAg-specific CTL responses in young mice in the presence of maternally transferred anti-HBs antibodies. However, B cell responses to both HBsAg/alum/CpG ODN and DNA vaccines remained weak in the presence of maternally transferred anti-HBs antibodies. (C) 2001 Federation of European Microbiological Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:241 / 247
页数:7
相关论文
共 50 条
  • [21] Synergistic and Additive Effects of Cimetidine and Levamisole on Cellular Immune Responses to Hepatitis B virus DNA Vaccine in Mice
    Niu, X.
    Yang, Y.
    Wang, J.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2013, 77 (02) : 84 - 91
  • [22] Conjugation of HIV-1 envelope to hepatitis B surface antigen alters vaccine responses in rhesus macaques
    Nettere, Danielle
    Unnithan, Shakthi
    Rodgers, Nicole
    Nohara, Junsuke
    Cray, Paul
    Berry, Madison
    Jones, Caroline
    Armand, Lawrence
    Li, Shuk Hang
    Berendam, Stella J.
    Fouda, Genevieve G.
    Cain, Derek W.
    Spence, Taylor N.
    Granek, Joshua A.
    Davenport, Clemontina A.
    Edwards, Robert J.
    Wiehe, Kevin
    Van Rompay, Koen K. A.
    Moody, M. Anthony
    Permar, Sallie R.
    Pollara, Justin
    NPJ VACCINES, 2023, 8 (01)
  • [23] Protective Anti-Hepatitis B Virus Responses in Rhesus Monkeys Primed with a Vectored Measles Virus and Boosted with a Single Dose of Hepatitis B Surface Antigen
    Valle, Jorge Reyes-del
    Hodge, Gregory
    McChesney, Michael B.
    Cattaneo, Roberto
    JOURNAL OF VIROLOGY, 2009, 83 (17) : 9013 - 9017
  • [24] Ubiquitin Conjugation of Hepatitis B Virus Core Antigen DNA Vaccine Leads to Enhanced Cell-Mediated Immune Response in BALB/c Mice
    Chen, Jian-Hua
    Yu, Yong-Sheng
    Liu, Hong-Hong
    Chen, Xiao-Hua
    Xi, Min
    Zang, Guo-Qing
    Tang, Zheng-Hao
    HEPATITIS MONTHLY, 2011, 11 (08) : 620 - 628
  • [25] Parenteral and mucosal prime-boost immunization strategies in mice with hepatitis B surface antigen and CpG DNA
    McCluskie, MJ
    Weeratna, RD
    Payette, PJ
    Davis, HL
    FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2002, 32 (03): : 179 - 185
  • [26] DNA based immunization against hepatitis B surface antigen (HBsAg) in normal and HBsAg-transgenic mice
    Davis, HL
    Millan, CLB
    Mancini, M
    McCluskie, MJ
    Hadchouel, M
    Comanita, L
    Tiollais, P
    Whalen, RG
    Michel, ML
    VACCINE, 1997, 15 (08) : 849 - 852
  • [27] Immune modulator and antiviral potential of dendritic cells pulsed with both hepatitis B surface antigen and core antigen for treating chronic HBV infection
    Akbar, Sheikh Mohammad Fazle
    Yoshida, Osamu
    Chen, Shiyi
    Cesar, Aguilar Julio
    Abe, Masanori
    Matsuura, Bunzo
    Hiasa, Yoichi
    Onji, Morikazu
    ANTIVIRAL THERAPY, 2010, 15 (06) : 887 - 895
  • [28] Dendritic cell-based vaccination with lentiviral vectors encoding ubiquitinated hepatitis B core antigen enhances hepatitis B virus-specific immune responses in vivo
    Dai, Shenglan
    Zhuo, Meng
    Song, Linlin
    Chen, Xiaohua
    Yu, Yongsheng
    Tang, Zhenghao
    Zang, Guoqing
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2015, 47 (11) : 870 - 879
  • [29] The Wild-Type Hepatitis C Virus Core Inhibits Initiation of Antigen-Specific T- and B-Cell Immune Responses in BALB/c Mice
    Zhu, Wenbo
    Chang, Yanzi
    Wu, Chunchen
    Han, Qingxia
    Pei, Rongjuan
    Lu, Mengji
    Chen, Xinwen
    CLINICAL AND VACCINE IMMUNOLOGY, 2010, 17 (07) : 1139 - 1147
  • [30] Hepatitis B Surface Antigen S Gene is an Effective Carrier Molecule for Developing GnRH DNA Immunocastration Vaccine in Mice
    Han, Y. G.
    Ye, W. J.
    Liu, G. Q.
    Jiang, X. P.
    Ijaz, N.
    Zhao, J. Y.
    Tesema, B.
    REPRODUCTION IN DOMESTIC ANIMALS, 2016, 51 (03) : 445 - 450